Ilham Benassou is Sub-Region Head in Drug Regulatory Affairs within the Region Europe & Greater China at Novartis in Basel, Switzerland.
She joined Novartis in 2006 and worked as EU RA manager and then as Global RA Director in several therapeutic areas including anti-infective, transplantation and Women & Health products. She has track record of successful submissions and regulatory experience on products spanning from phase I to Phase IV. In her current role, she is providing regulatory leadership for more than 20 countries across the European continent including a role as Regulatory Lead for the IMI SAFE-T consortium for the qualification of clinical safety biomarkers.
Prior to joining Novartis, Ilham Benassou was intern research scientist at the PASTEUR Institute in Paris where she graduated with a Bachelor Degree in biochemistry. She then trained as biotechnology engineer from University of Sciences in Rouen. She completed her education at the University of Pharmacy in Paris XI with a Master Degree in biotechnology and international regulatory affairs.